ESTRO-EPTN guidelines for independent dose calculation and log file-based patient-specific quality assurance in scanned particle therapy
Physics and Imaging in Radiation Oncology · 2026-09 · 41 · 101109
DOI: 10.1016/j.phro.2026.101109 ↗Kurz gefasst
Leitlinie in der Zeitschrift Physics and Imaging in Radiation Oncology, 2026-09. Verfasst von Loïc Grevillot und 31 weiteren Autor:innen. Beteiligte Einrichtung: MedAustron Ion Therapy Center, Wiener Neustadt, Austria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND AND PURPOSE: Independent dose calculation (IDC) and log file-based patient-specific quality assurance (PSQA) are increasingly used in scanned particle therapy (PT) to address pitfalls of phantom-based verifications. Highly modulated treatment fields, steep dose gradients, and growing interest for adaptive treatments require quality assurance (QA) approaches that are cost effective, patient-specific, and closely linked to the delivered treatment. Practical guidance is therefore needed for the safe clinical implementation of IDC- and log file-based PSQA. MATERIALS AND METHODS: The ESTRO-EPTN (European Particle Therapy Network) developed consensus-based recommendations on IDC- and log file-based PSQA in PT. Current clinical practice, commissioning strategies, risk-management approaches, and available technical solutions were evaluated. Following a review of the literature, expert-based guidelines were developed covering clinical scopes, acceptance, commissioning and validation, integration with machine QA, data management, governance, and staged implementation. RESULTS: IDC- and log file-based PSQA were identified as complementary elements within a quality-management framework. Log file-based approaches enable evaluation of the delivered treatment fraction(s), while IDC provides computational verification of the planned dose. When appropriately validated, these methods increase sensitivity to potentially clinically relevant deviations and can substantially reduce reliance on phantom-based measurements. Safe application requires robust machine QA, characterization of model limitations, risk analysis, and data traceability. Recommendations applicable to all centers were developed for IDC. Log file-based PSQA recommendations include minimum requirements for the vendors. CONCLUSIONS: These recommendations aim to promote consistent and safe adoption across PT centers, while preserving the need for machine QA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MedAustron Ion Therapy Center, Wiener Neustadt, Austria.
- Heidelberg Ion Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
- National Center for Radiation Research in Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany.
- Division of Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre (MAHSC), Manchester, United Kingdom.
- Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.
Zitieren
APA
Grevillot, L., Jäkel, O., Qubala, A., Horn, J., Aitkenhead, A. H., Liang, X., Magro, G., Badraoui-Čuprová, K., Vilimovský, J., Wulff, J., Henkner, K., Clark, C. H., Skrijelj, D., Rinaldi, I., Souris, K., Rossomme, S., Lebbink, F., Hong, L., Krzempek, D., …, & Vidal, M. (2026). ESTRO-EPTN guidelines for independent dose calculation and log file-based patient-specific quality assurance in scanned particle therapy. Physics and Imaging in Radiation Oncology, 41, 101109. https://doi.org/10.1016/j.phro.2026.101109
Vancouver
Grevillot L, Jäkel O, Qubala A, Horn J, Aitkenhead AH, Liang X, et al. ESTRO-EPTN guidelines for independent dose calculation and log file-based patient-specific quality assurance in scanned particle therapy. Physics and Imaging in Radiation Oncology. 2026;41:101109. doi:10.1016/j.phro.2026.101109
BibTeX
@article{Grevillot2026,
author = {Grevillot, Loïc and Jäkel, Oliver and Qubala, Abdallah and Horn, Julian and Aitkenhead, Adam H and Liang, Xiaoying and Magro, Giuseppe and Badraoui-Čuprová, Klará and Vilimovský, Jan and Wulff, Jörg and Henkner, Katrin and Clark, Catharine H and Skrijelj, Damir and Rinaldi, Ilaria and Souris, Kevin and Rossomme, Séverine and Lebbink, Franciska and Hong, Liu and Krzempek, Dawid and Menkel, Stefan and Janson, Martin and Jensen, Maria Fuglsang and Gosling, Andrew and Bäckström, Gloria and Emert, Frank and Schwamm, Frank and Safai, Sairos and Free, Jeffrey and Guterres Marmitt, Gabriel and Bello Garrote, Frank L and Stolarczyk, Liliana and Vidal, Marie},
title = {ESTRO-EPTN guidelines for independent dose calculation and log file-based patient-specific quality assurance in scanned particle therapy},
journal = {Physics and Imaging in Radiation Oncology},
year = {2026},
volume = {41},
pages = {101109},
doi = {10.1016/j.phro.2026.101109}
}
EUVIMED